(Data sent by the signing company)
Lesaffre, a major global fermentation and microorganism company, has announced a series of investments in the United States to strengthen its geographic presence in the region, respond to growth in nutrition and health, and better serve its customers.
Marc-en-Barol, France, November 20, 2023 /PRNewswire/ — Lesaffre, which has been in the United States since 1978, has more than 600 employees in this country at its yeast and bacteria factories, bakery ingredients, baking center and corporate headquarters. The Group continues to grow through capital investments and various acquisitions, expanding its business and adapting to the new needs of its clients in the fields of nutrition, health and biotechnology.
With the aim of feeding 9 billion people by 2050, Lesaffre invests in both new equipment and R&D to be as close as possible to its customers and offer them the most relevant solutions, while respecting the planet’s finite resources. Further expansion into the US is strategic for Lesaffre, hence the several investments made in 2023.
The tenth fermenter of the yeast factory Cedar slopes (yeah)
To meet the growing demand from the nutrition and biotechnology sectors, while continuing to serve existing customers well, Red star yeast, LLC, implemented a new brewing operation on August 31. This additional capacity to serve the baking, nutrition, healthcare and biotechnology sectors provides flexibility and adaptability to customers, allowing Lesaffre and Red Star Yeast Company to move forward with solutions to meet the food challenges of the future.
New dried yeast extract plant Cedar slopes (yeah)
In this plant (Cedar Rapids, Iowa).Lesaffre has invested in a new dryer to meet the growing customer demand of Phileo, the Lesaffre business unit dedicated to animal nutrition and health, while taking a more environmentally friendly approach by reducing carbon emissions.
Acquisition of genetic engineering technology
Lesaffre has acquired the capabilities of a bioscience company headquartered in Massachusetts Focused on molecules of natural origin for the benefit of human health, which joins the Les Sèvres Institute of Science and Technology. This investment expands the metabolic engineering capabilities of the Lesaffre Recombia Biosciences entity, with new laboratories opening in November 2023.
This new investment will allow Lesaffre and Recombia to explore the potential of plant metabolites that are produced through microfermentation processes in bacteria and yeast, as well as their multiple interactions with microorganisms.
Lesaffre – Working together to better nourish and protect the planet.
More information about Lesaffre on www.lesaffre.com
communication: [email protected]